Company intelligence / Profile preview

STARmed

Goyang-si, Gyeonggi-do, South Koreastarmed.care ↗

Ownership: Private
Employees: ~100
Development stage: Commercial

Overview

STARmed is a global leader in radiofrequency ablation technology for minimally invasive treatment of various solid organ diseases. Their VIVA combo RF System was first to receive FDA clearance for thyroid RFA in the US. Over 70% of clinical studies on thyroid RFA use their devices due to strong safety and efficacy data with low complication rates. The company’s portfolio includes four generator systems and over ten electrode types serving diverse clinical needs across more than six organ systems.

Therapeutic areas: OncologyEndocrinologyGastroenterologyNephrologyWomen's Health
Modalities: DeviceRadiofrequency ablation system
Industry: Therapeutic Medical Devices

Partnerships

No major pharma partners listed

Beyond the preview

Go deeper on STARmed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STARmed.

Explore the full profile